Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
Recruiting
Observational Study
Lung Nodule
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 89
- Sex
- Any
- Study type
- Observational
- Participants needed
- 45,991 (estimated)
- Sponsor
- University Hospitals Cleveland Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
chest x-rays will be analyzed by AI software for a secondary read of lung nodules. Chest x-rays will either be sent to the AI tool to be read or to radiologists to read. If the image is sent to the AI tool, the AI software will generate a report on if it detects a lung nodule or not. The image will then be sent to a radiologist to determine if there is agreement or disagreement with the AI tool.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Chest X-ray images of patients aged 18 - 89 years.
* Modality: CR/DR/DX.
* PA/view
* Lung nodules measuring 6 mm -30 mm (for chest X-ray images where presence of nodules is required).
Exclusion Criteria:
* Incomplete view of the chest.
* Lateral view
* Known lung cancer at t…
Contacts